Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Inhibitor Therapeutics, Inc./ 10-K

Annual Report · 10-K

Inhibitor Therapeutics, Inc.

INTIOTCEQUITYCurrent

Annual Report

Filed Mar 31, 2023Accepted Mar 31, 2023, 1:01 PM EDTCIK 1042418Accession 0001493152-23-010383
View company →Permanent SEC source ↗
Share

Company context

Current securities

INTIOTC · EQUITY · Current

Recent company filings

  1. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security HoldersSep 18, 2026
  2. DEF 14A filingAug 17, 2026
  3. 10-Q filingAug 14, 2026
  4. 4 filingJun 1, 2026
  5. 10-Q filingMay 15, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗